Product
Trifluridine + Tipiracil + Fufuquitinib
1 clinical trial
2 indications
Indication
Colorectal CancerIndication
Drug TherapyClinical trial
Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib Versus Trifluridine/Tipiracil and Fufuquitinib for Third-line Treatment of Unresectable Metastatic Colorectal CancerStatus: Recruiting, Estimated PCD: 2026-06-01